Obesity is a known risk factor for cardiovascular disease, but people's weights can shift over time, and little is known ...

Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...

The development of GLP-1 drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, there are concerns about the ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

After a full data analysis, Altimmune is heralding phase 2 obesity data for pemvidutide as “best-in-class” for spurring weight loss while preserving lean mass. The small biotech is going up against ...

Weight loss treatments do more than reduce weight, they subtly alter body composition, raising new scientific questions about their full impact.

Individuals stopping GLP-1 receptor agonists regain most lost weight within 1 year, but about one quarter of the weight ...

Adjusted body weight is used to calculate weight, which considers lean and fat mass. This tool can help provide more precise medical and nutritional assessments. Healthcare professionals often use ...

A protein called B cell lymphoma 6 (BCL6) could be key to maintaining healthy muscle mass, and potentially could be used to combat muscle wasting conditions in humans, a study in mice suggests.

US WITH THE ANSWER TODAY. WELL, BEN, THE DOCTOR I SPOKE TO FROM TUFTS MEDICAL CENTER SAYS IT’S BEEN FRUSTRATING NAVIGATING THESE INSURANCE CHANGES. BUT HEALTH PLAN EXPERTS SAY IT’S JUST UNSUSTAINABLE ...